Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

BNC105: A Novel Tubulin Polymerization Inhibitor That Selectively Disrupts Tumor Vasculature and Displays Single-Agent Antitumor Efficacy

Mol Cancer Ther (2010) 9 (6): 1562–1573.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization
  • Wen Ren
  • Yuling Deng
  • Jacob D. Ward
  • Rebecca Vairin
  • Ruoli Bai
  • Hashini I. Wanniarachchi
  • Khagendra B. Hamal
  • Pouguiniseli E. Tankoano
  • Caleb S. Tamminga
  • Lorena M.A. Bueno
  • Ernest Hamel
  • Ralph P. Mason
  • Mary Lynn Trawick
  • Kevin G. Pinney
European Journal of Medicinal Chemistry (2024) 263: 115794.
Discovery, synthesis, activities, structure–activity relationships, and clinical development of combretastatins and analogs as anticancer drugs. A comprehensive review
  • Sheo B. Singh
Natural Product Reports (2024) 41 (2): 298.
Design, synthesis, and antitumor evaluation of trimethoxyflavonoid with arylurea structure against hepatocellular carcinoma
  • Xueyan Sun
  • Yin Zhao
  • Jingduo Zhao
  • Zhizhong Xie
  • Xiaoyong Lei
  • Xingyun Liu
  • Yong Li
  • Sheng Huang
  • Zhe Wang
  • Guotao Tang
Drug Development Research (2023) 84 (3): 448.
Synthesis and anti-hepatocellular carcinoma evaluation of salicylic acid-modified indole trimethoxy flavonoid derivatives
  • Yang Zou
  • Na Lu
  • Xiaoyan Yang
  • Zhizhong Xie
  • Xiaoyong Lei
  • Xingyun Liu
  • Yong Li
  • Sheng Huang
  • Guotao Tang
  • Zhe Wang
RSC Medicinal Chemistry (2023) 14 (6): 1172.
Synthesis and evaluation of benzoylbenzofurans and isoflavone derivatives as sirtuin 1 inhibitors with antiproliferative effects on cancer cells
  • Mamoalosi A. Selepe
  • Phaladi Kunyane
  • Pule Seboletswe
  • Shankari Nair
  • Nosipho Cele
  • Monique Engelbrecht
  • Daniël F. Joubert
  • Charlot Vandevoorde
  • Parvesh Singh
  • Molahlehi S. Sonopo
Bioorganic Chemistry (2022) 128: 106101.
Taccalonolides: Structure, semi-synthesis, and biological activity
  • Yan Li
  • Yu-Feng Du
  • Feng Gao
  • Jin-Bu Xu
  • Ling-Li Zheng
  • Gang Liu
  • Yu Lei
Frontiers in Pharmacology (2022) 13
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
  • Her-Shyong Shiah
  • Nai-Jung Chiang
  • Chia-Chi Lin
  • Chia-Jui Yen
  • Hui-Jen Tsai
  • Shang-Yin Wu
  • Wu-Chou Su
  • Kwang-Yu Chang
  • Ching-Chiung Wang
  • Jang-Yang Chang
  • Li-Tzong Chen
The Oncologist (2021) 26 (4): e567.
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent
  • Eddy S. Yang
  • Amin H. Nassar
  • Elio Adib
  • Opeyemi A. Jegede
  • Sarah Abou Alaiwi
  • Deborah L. Della Manna
  • David A. Braun
  • Mahsa Zarei
  • Heng Du
  • Sumanta K. Pal
  • Gurudatta Naik
  • Guru P. Sonpavde
Molecular Cancer Therapeutics (2021) 20 (8): 1454.
A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin
  • Jinghong Xian
  • Faqian Bu
  • Yuxi Wang
  • Fangyi Long
  • Zhixiong Zhang
  • Chengyong Wu
  • Yiran Tao
  • Ting Wang
  • Guan Wang
Molecules (2021) 26 (4): 946.
Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors
  • Yvonne Kraus
  • Carina Glas
  • Benedikt Melzer
  • Li Gao
  • Constanze Heise
  • Monique Preuße
  • Julia Ahlfeld
  • Franz Bracher
  • Oliver Thorn-Seshold
European Journal of Medicinal Chemistry (2020) 186: 111865.
Synthesis of Arylidene – Isoquinolinones bearing Combretastatin Skeleton by Cyclocarbopalladation/cross coupling Tandem Heck‐Suzuki Miaura Reactions using nano catalyst Pd@Py‐IL‐SPION
  • Mohammad Sadegh Asgari
  • Parviz Rashidi Ranjbar
  • Rahmatollah Rahimi
  • Mohammad Mahdavi
Applied Organometallic Chemistry (2020) 34 (2)
Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site
  • Xi Hu
  • Lu Li
  • Qiangsheng Zhang
  • Qianqian Wang
  • Zhanzhan Feng
  • Ying Xu
  • Yong Xia
  • Luoting Yu
Bioorganic Chemistry (2020) 97: 103695.
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors
  • Paola Oliva
  • Romeo Romagnoli
  • Stefano Manfredini
  • Andrea Brancale
  • Salvatore Ferla
  • Ernest Hamel
  • Roberto Ronca
  • Federica Maccarinelli
  • Arianna Giacomini
  • Fatlum Rruga
  • Elena Mariotto
  • Giampietro Viola
  • Roberta Bortolozzi
European Journal of Medicinal Chemistry (2020) 200: 112448.
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia
  • Felice Pepe
  • Veronica Balatti
Journal of Clinical Medicine (2020) 9 (2): 593.
Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design
  • Tao Wang
  • Chengyong Wu
  • Chengdi Wang
  • Guiping Zhang
  • Kinsie E. Arnst
  • Yijun Yao
  • Zhixiong Zhang
  • Yuxi Wang
  • Dan Pu
  • Weimin Li
Biochemical and Biophysical Research Communications (2020) 525 (1): 148.
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
  • Eavan C. McLoughlin
  • Niamh M. O’Boyle
Pharmaceuticals (2020) 13 (1): 8.
Unexpected Oxidative Ring Opening of Electron-Rich 3-Aminobenzofurans into α-Ketoimines Derivatives
  • Ilhem Khelifi
  • Guangkuan Zhao
  • Nour-Eddine Ghermani
  • Olivier Provot
  • Mouad Alami
The Journal of Organic Chemistry (2019) 84 (4): 1725.
Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents
  • Chao Tian
  • Xuanzhen Chen
  • Zhili Zhang
  • Xiaowei Wang
  • Junyi Liu
European Journal of Medicinal Chemistry (2019) 183: 111679.
Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site
  • Ling Li
  • Sibo Jiang
  • Xiaoxun Li
  • Yao Liu
  • Jing Su
  • Jianjun Chen
European Journal of Medicinal Chemistry (2018) 151: 482.
Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β -lactam bridged combretastatin A-4 analogues as potent antitumor agents
  • Pengfei Zhou
  • Yuru Liang
  • Hao Zhang
  • Hao Jiang
  • Kechang Feng
  • Pan Xu
  • Jie Wang
  • Xiaoming Wang
  • Kuiling Ding
  • Cheng Luo
  • Mingming Liu
  • Yang Wang
European Journal of Medicinal Chemistry (2018) 144: 817.
Design, synthesis and biological evaluation of 3′,4′,5′-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents
  • Zhe Wang
  • Xiangping Deng
  • Runde Xiong
  • Shujuan Xiong
  • Juan Liu
  • Xuan Cao
  • Xiaoyong Lei
  • Yanming Chen
  • Xing Zheng
  • Guotao Tang
MedChemComm (2018) 9 (2): 305.
Design, synthesis and biological evaluation of flavonoid salicylate derivatives as potential anti-tumor agents
  • Xiangping Deng
  • Zhe Wang
  • Juan Liu
  • Shujuan Xiong
  • Runde Xiong
  • Xuan Cao
  • Yanming Chen
  • Xing Zheng
  • Guotao Tang
RSC Advances (2017) 7 (61): 38171.
Deciphering the origins of molecular toxicity of combretastatin A4 and its glycoconjugates: interactions with major drug transporters and their safety profiles in vitro and in vivo
  • Zhenhua Huang
  • Gentao Li
  • Xue Wang
  • Hu Xu
  • Youcai Zhang
  • Qingzhi Gao
MedChemComm (2017) 8 (7): 1542.
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
  • Darcy Bates
  • Alan Eastman
British Journal of Clinical Pharmacology (2017) 83 (2): 255.
Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth
  • María-Jesús Pérez-Pérez
  • Eva-María Priego
  • Oskía Bueno
  • Maria Solange Martins
  • María-Dolores Canela
  • Sandra Liekens
Journal of Medicinal Chemistry (2016) 59 (19): 8685.
Not flavone-8-acetic acid (FAA) but its murine metabolite 6-OH-FAA exhibits remarkable antivascular activities in vitro
  • Minh Hien Pham
  • Daniel Dauzonne
  • Guy G. Chabot
Anti-Cancer Drugs (2016) 27 (5): 398.
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105
  • Darcy Bates
  • Edmond J. Feris
  • Alexey V. Danilov
  • Alan Eastman
Cancer Biology & Therapy (2016) 17 (3): 291.
Synthesis of [3-13C]-2,3-dihydroxy-4-methoxybenzaldehyde
  • Rebecca C. Collins
  • Martyn N. Paley
  • Gillian M. Tozer
  • Simon Jones
Tetrahedron Letters (2016) 57 (5): 563.
Early investigational tubulin inhibitors as novel cancer therapeutics
  • Kunal Nepali
  • Ritu Ojha
  • Hsueh-Yun Lee
  • Jing-Ping Liou
Expert Opinion on Investigational Drugs (2016) 25 (8): 917.
Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity
  • Luma G. Magalhaes
  • Fernando B. Marques
  • Marina B. da Fonseca
  • Kamilla R. Rogério
  • Cedric S. Graebin
  • Adriano D. Andricopulo
  • Irina V Lebedeva
PLOS ONE (2016) 11 (8): e0160842.
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation
  • Elena Porcù
  • Luca Persano
  • Roberto Ronca
  • Stefania Mitola
  • Roberta Bortolozzi
  • Romeo Romagnoli
  • Paola Oliva
  • Giuseppe Basso
  • Giampietro Viola
Scientific Reports (2016) 6 (1)
Effect of CPU-XT-008, a combretastatin A-4 analogue, on the proliferation, apoptosis and expression of vascular endothelial growth factor and basic fibroblast growth factor in human umbilical vein endothelial cells
  • RUI XIONG
  • JING SUN
  • KUN LIU
  • YUNGEN XU
  • SHUYING HE
Oncology Letters (2016) 11 (1): 491.
Synthesis and biological evaluation of benzocyclooctene-based and indene-based anticancer agents that function as inhibitors of tubulin polymerization
  • Christine A. Herdman
  • Tracy E. Strecker
  • Rajendra P. Tanpure
  • Zhi Chen
  • Alex Winters
  • Jeni Gerberich
  • Li Liu
  • Ernest Hamel
  • Ralph P. Mason
  • David J. Chaplin
  • Mary Lynn Trawick
  • Kevin G. Pinney
MedChemComm (2016) 7 (12): 2418.
Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis
  • Souvik Banerjee
  • Dong-Jin Hwang
  • Wei Li
  • Duane Miller
Molecules (2016) 21 (11): 1468.
Metal‐Free Radical 5‐exo‐dig Cyclizations of Phenol‐Linked 1,6‐Enynes for the Synthesis of Carbonylated Benzofurans
  • Ming Hu
  • Ren‐Jie Song
  • Jin‐Heng Li
Angewandte Chemie International Edition (2015) 54 (2): 608.
The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts
  • Tracy E. Strecker
  • Samuel O. Odutola
  • Ramona Lopez
  • Morgan S. Cooper
  • Justin K. Tidmore
  • Amanda K. Charlton-Sevcik
  • Li Li
  • Matthew T. MacDonough
  • Mallinath B. Hadimani
  • Anjan Ghatak
  • Li Liu
  • David J. Chaplin
  • Ralph P. Mason
  • Kevin G. Pinney
  • Mary Lynn Trawick
Cancer Letters (2015) 369 (1): 229.
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
  • Sumanta Pal
  • Arun Azad
  • Shailender Bhatia
  • Harry Drabkin
  • Brian Costello
  • John Sarantopoulos
  • Ravindran Kanesvaran
  • Richard Lauer
  • Alexander Starodub
  • Ralph Hauke
  • Christopher J. Sweeney
  • Noah M. Hahn
  • Guru Sonpavde
  • Stephen Richey
  • Timothy Breen
  • Gabriel Kremmidiotis
  • Annabell Leske
  • Elizabeth Doolin
  • David C. Bibby
  • Jeremy Simpson
  • Jose Iglesias
  • Thomas Hutson
Clinical Cancer Research (2015) 21 (15): 3420.
Metal‐Free Radical 5‐exo‐dig Cyclizations of Phenol‐Linked 1,6‐Enynes for the Synthesis of Carbonylated Benzofurans
  • Ming Hu
  • Ren‐Jie Song
  • Jin‐Heng Li
Angewandte Chemie (2015) 127 (2): 618.
Synthesis and anti-cancer screening of novel heterocyclic-(2H)-1,2,3-triazoles as potential anti-cancer agents
  • Narsimha Reddy Penthala
  • Leena Madhukuri
  • Shraddha Thakkar
  • Nikhil Reddy Madadi
  • Gauri Lamture
  • Robert L. Eoff
  • Peter A. Crooks
MedChemComm (2015) 6 (8): 1535.
Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes
  • Hsueh-Yun Lee
  • Chih-Yi Chang
  • Mei-Jung Lai
  • Hsun-Yueh Chuang
  • Ching-Chuan Kuo
  • Chi-Yen Chang
  • Jang-Yang Chang
  • Jing-Ping Liou
Bioorganic & Medicinal Chemistry (2015) 23 (15): 4230.
Design, Synthesis, in Vitro, and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylaminobenzofuran Derivatives Targeting the Colchicine Site on Tubulin
  • Romeo Romagnoli
  • Pier Giovanni Baraldi
  • Maria Kimatrai Salvador
  • Filippo Prencipe
  • Carlota Lopez-Cara
  • Santiago Schiaffino Ortega
  • Andrea Brancale
  • Ernest Hamel
  • Ignazio Castagliuolo
  • Stefania Mitola
  • Roberto Ronca
  • Roberta Bortolozzi
  • Elena Porcù
  • Giuseppe Basso
  • Giampietro Viola
Journal of Medicinal Chemistry (2015) 58 (7): 3209.
A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells
  • Jun Yan
  • Yanqing Pang
  • Jianfeng Sheng
  • Yali Wang
  • Jie Chen
  • Jinhui Hu
  • Ling Huang
  • Xingshu Li
Biochemical Pharmacology (2015) 97 (1): 51.
Tubulin Inhibitor Identification by Bioactive Conformation Alignment Pharmacophore‐Guided Virtual Screening
  • Shanthi Nagarajan
  • Min Jeong Choi
  • Yong Seo Cho
  • Sun‐Joon Min
  • Gyochang Keum
  • Soo Jin Kim
  • Chang Sik Lee
  • Ae Nim Pae
Chemical Biology & Drug Design (2015) 86 (5): 998.
The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer
  • Daniel J Inglis
  • Tina C Lavranos
  • Donna M Beaumont
  • Annabell F Leske
  • Chloe K Brown
  • Allison J Hall
  • Gabriel Kremmidiotis
Cancer Biology & Therapy (2014) 15 (11): 1552.
Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents
  • Samir Mehndiratta
  • Yi-Fang Chiang
  • Mei-Jung Lai
  • Hsueh-Yun Lee
  • Mei-Chuan Chen
  • Ching-Chuan Kuo
  • Chi-Yen Chang
  • Jang-Yang Chang
  • Jing-Ping Liou
Bioorganic & Medicinal Chemistry (2014) 22 (17): 4917.
Antimitotic and vascular disrupting agents: 2-Hydroxy-3,4,5-trimethoxybenzophenones
  • Chih-Yi Chang
  • Hsun-Yueh Chuang
  • Hsueh-Yun Lee
  • Teng-Kuang Yeh
  • Ching-Chuan Kuo
  • Chi-Yen Chang
  • Jang-Yang Chang
  • Jing-Ping Liou
European Journal of Medicinal Chemistry (2014) 77: 306.
Recent Advances in Vascular Disrupting Agents in Cancer Therapy
  • Elena Porcù
  • Roberta Bortolozzi
  • Giuseppe Basso
  • Giampietro Viola
Future Medicinal Chemistry (2014) 6 (13): 1485.
Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents
  • Rajendra P. Tanpure
  • Clinton S. George
  • Tracy E. Strecker
  • Laxman Devkota
  • Justin K. Tidmore
  • Chen-Ming Lin
  • Christine A. Herdman
  • Matthew T. MacDonough
  • Madhavi Sriram
  • David J. Chaplin
  • Mary Lynn Trawick
  • Kevin G. Pinney
Bioorganic & Medicinal Chemistry (2013) 21 (24): 8019.
Synthesis of a 2-Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A-4 with Application as a Vascular Disrupting Agent
  • Mallinath B. Hadimani
  • Matthew T. MacDonough
  • Anjan Ghatak
  • Tracy E. Strecker
  • Ramona Lopez
  • Madhavi Sriram
  • Benson L. Nguyen
  • John J. Hall
  • Raymond J. Kessler
  • Anupama R. Shirali
  • Li Liu
  • Charles M. Garner
  • George R. Pettit
  • Ernest Hamel
  • David J. Chaplin
  • Ralph P. Mason
  • Mary Lynn Trawick
  • Kevin G. Pinney
Journal of Natural Products (2013) 76 (9): 1668.
Synthesis and Structure–Activity Relationships of N-Methyl-5,6,7-trimethoxylindoles as Novel Antimitotic and Vascular Disrupting Agents
  • Deng-Gao Zhao
  • JianJun Chen
  • Ya-Rong Du
  • Yan-Yan Ma
  • Ya-Xiong Chen
  • Kun Gao
  • Bu-Rong Hu
Journal of Medicinal Chemistry (2013) 56 (4): 1467.
  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept